NCT00617201View on ClinicalTrials.gov

Evaluation of Atomoxetine for Cocaine Dependence: A Pilot Trial

PHASE2CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

July 31, 2007

Primary Completion Date

August 31, 2011

Study Completion Date

August 31, 2011

Conditions
Substance Abuse
Interventions
DRUG

atomoxetine

Once daily oral dosing

DRUG

placebo

Once daily oral dosing - matched placebo

Trial Locations (1)

40502

Straus Research Building, Lexington

All Listed Sponsors
collaborator

Eli Lilly and Company

INDUSTRY

collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

Sharon Walsh

OTHER

NCT00617201 - Evaluation of Atomoxetine for Cocaine Dependence: A Pilot Trial | Biotech Hunter | Biotech Hunter